- Summits
- Sponsorship
- News
- About
Hilton, West Palm Beach, Florida, USA
May 5-7th, 2027
10:00 – 12:00
Start our conference with Florida lifestyle experience. Enjoy the beauty and allure of Palm Beach from the water on 120-minute entertaining cruise on a brand new Catamaran.
Exclusive for Platinum ticket holders only.
14:00 – 16:30
By Application Only Held at Canopy by Hilton, West Palm Beach
Participation in the CEO-Only Forum sponsored by Malta Enterprise is strictly limited to current Chief Executive Officers of active medical device startups. All participants must hold a valid Conference Pass to attend. Each application will be reviewed by the MedTech World team and will be either be accepted or declined based on these criteria.
14:00 – 16:30
By Application Only Held at Canopy by Hilton, West Palm Beach
Participation in the Investor-Only Forum sponsored by Greenberg Traurig is strictly limited to active investors in the medtech ecosystem. Eligible participants include venture capital firms, angel investors, family offices, corporate venture arms, and hospital investment representatives. All participants must hold a valid Conference Pass to attend. Each application will be reviewed by the MedTech World team and will be either accepted or declined based on these criteria.
17:30 – 20:30
Pre-Registration and Networking Reception
All Ticket Holders. Sponsored by CS Lifesciences and Co-Hosted by MedTech World & Bio Florida.
Location: Mezze Restaurant at Hilton West Palm Beach.
19:30 – 23:00
The MedTech World Awards USA will mark our first-ever awards ceremony in the United States, celebrating excellence and innovation across the MedTech and HealthTech landscape. Honoring startups, investors, clinicians, and ecosystem builders, the ceremony will spotlight the individuals and organizations pushing healthcare forward. Sponsored by Blue Goat Cyber, this milestone event will set the tone for recognizing MedTech leadership on a truly global stage. The awards ceremony will take place at the Oceana Ballroom at the Hilton West Palm Beach.
Access is strictly limited to Platinum ticket holders, and prior RSVP is required.
08:00 – 18:00
The agenda is designed for action in 2026, covering how to win in enterprise health systems, navigate market access and regulatory readiness, raise capital and plan for outcomes, partner with strategics and health systems, and spot the next wave of breakout innovation across robotics, women’s health, neuro, and emerging device categories. The conference will conclude with a live startup pitch competition, featuring a hand selected cohort presenting on stage in front of an investor judging panel.
Dr. Dylan Attard
CEO, Founder
MedTech World
H.E. Dr Godfrey Carmel Xuereb
Ambassador of the Republic of Malta to the United States
Embassy of the Republic of Malta
A discussion on what it really takes for startups and innovators to break into large health systems in 2026. Leaders from health systems, legal, and policy will share how procurement decisions are made, what buyers actually look for, and how companies can navigate pilots, partnerships, and scale.
Wael Barsoum
President and Chief Transformation Officer
Healthcare Outcomes Performance Company (HOPCo)
George Stephen LeMieux
Chairman of the Board
Gunster
Dr. Dipen J Parekh
CEO, Executive Vice President
University of Miami Health System, UHealth, Health Affairs at the University of Miami
Mary C. Mayhew
President & CEO
Florida Hospital Association
Cody Simmons
Co-Founder & CEO
DermaSensor Inc
This panel will explore what it really takes to enter and grow in the US market, from navigating regulatory pathways and reimbursement strategy to securing your first commercial customers. Speakers will share practical insights on how startups can align clinical, regulatory, and go to market planning early to avoid costly delays and build a stronger path to adoption.
Blythe Karow
Founder & Principal
The Karow Advisory Group
Angela Paterson
Principal Consultant
CS Life Sciences
Mercè Guerra
Associate Director, Regulatory Affairs Medtech
Alira Health
Danielle E. Sapega
Member
Cozen O'Connor
Dr. Jose Osorio
Electrophysiologist, Founder, Strategic Advisor, and Managing Partner
3PH Alliance | NuPulse Capital
Farrukh Usman
Founder & CEO
Byonyks
Rigu Gupta
CEO
PIROGON, Inc
Andreas Forsland
Founder & CEO
Cognixion
Reginald Allouche
CEO and co-founder
Paltech
Rajit Kamal
Vice President and General Manager, Surgical Robotics
Medtronic
Hospital venture funds provide more than capital, offering startups clinical access, validation pathways, and strategic partnerships. This panel explores how these investors work with founders through pilots, co-development, and collaborations with other VCs.
Alex Condon
COO
Matrix One
Anita Watkins
Managing Director
Rex Health Ventures / UNC Health
Sibo Gama Morales
Investment Associate
Orlando Health Ventures
Todd Schwarzinger, MBA
Partner, Innovations Ventures
Cleveland Clinic Innovations
Patrick Wayte
SVP, Center for Health Technology & Innovation
American Heart Association
This panel explores where investors are placing capital in MedTech in 2026, what themes are attracting the strongest interest, and what makes companies stand out in a more selective funding environment. Speakers will share a candid perspective on how capital is being deployed, which sectors are gaining attention, and what founders need to understand to raise successfully in today’s market.
Steven Levy
Partner
Unorthodox Ventures
Greg Madden
Managing Partner
SV Health Investors
Chris Japp
Partner
Tramway Ventures
Sid Arora
Vice President, Healthcare Investment Banking
Ernst & Young Capital Advisors
Eric Tansky
Head of Medical Technology Banking
Oppenheimer & Co. Inc.
John Gorski
Vice Chair, Board of Directors (former CEO)
NAMSA
Moving from prestige robots to practical, cost-effective platforms; financing models (leasing, per-use).
Manish Chand
Robotic Surgeon and Technology Researcher
University college London
Yathart Gupta
Director Strategic Finance (FP&A)
Karl Storz
Dr David Laith Rawaf
Clinical Director/Clinical Strategy & Partnerships
VitVio
Rachna Dayal
Managing Partner
Sugati Ventures
Rajit Kamal
Vice President and General Manager, Surgical Robotics
Medtronic
A successful commercialization strategy can make or break a MedTech startup. This panel will dive into how founders can prepare for market entry, avoid common pitfalls, and build the right foundations for adoption, revenue, and long term scale.
Ivanny Franklin
Managing Partner
MedSight Capital
Maunark S Patel
Co-Founder, CEO
Skuvent Inc
Tim Lawrie
Founder and CEO
ProjectUS Consulting
Claudia Holy
Founder and CEO
Podymos Ltd
Joe Sasson
Chief Commercial Officer and EVP, MedAxiom Ventures
MedAxiom
Presenting Slot
Murthy Anupindi
Co-Founder
ComplyWise
Siddarth Nandyala
Founder & CEO
Circadian AI
Manish Wadhwa MD FHRS FACC FESC
Chief Executive Officer
SummaCor
Underfunded but fast-growing: menopause, pelvic floor, oncology; how to build and commercialize in this space.
Desert Horse Grant
lead of innovation
Sylvester Comprehensive Cancer Center
Addie Harris
Partner
Precision Life Science Partners
Thorsten Waloschek
CEO
NeoPredics
Darshana Zaveri
Founder & Managing Partner
Catalyst Health Ventures (CHV)
Dr. Ashraf Affan
Founder & CEO
Angel Kids Pediatrics and Behavioral Health
How cardio care is moving beyond the hospital through remote monitoring, integrated care pathways, and reimbursement-ready models that connect health systems, innovators, and partners.
Christina J. Wurster
Chief Executive Officer
Heart Rhythm Society
Maulik Majmudar
Chief Medical Officer
Biofourmis
Dr. David Albert
Founder and Chief Medical Officer
AliveCor
Homer Quintana
Director, Center for Rapid Device Translation
Houston Methodist
Ken Nelson
Partner
MedTech Advantage Fund
Yulia Yurevich
Head of Client Relations & Partnerships
MedTech World
Invite Only
Christian Espinosa
CEO
Blue Goat Cyber
Edwin Lindsay
Principal Consultant / Managing Director
CS Lifesciences
Lori Ellis
Host
Open Door Salon
19:30 – 23:00
The Evening Networking VIP Reception, sponsored by Blue Goat Cyber, is exclusive to Platinum Access guests and will be held at IL Bellagio Italian Restaurant in West Palm Beach, FL. The reception will offer an intimate setting for high-level networking among investors, CEOs, and industry leaders. Set against Florida’s vibrant backdrop, the evening will combine fine hospitality with strategic introductions, fostering meaningful relationships that drive future collaborations. It’s where the conversations that shape MedTech’s next chapter will truly begin.
09:00 – 18:00
This panel explores how corporate venture investors evaluate MedTech opportunities through both a financial and strategic lens. Speakers will discuss what makes a company attractive to corporate capital, how strategic priorities shape investment decisions, and where startups often misunderstand the expectations, risks, and opportunities that come with this type of investor.
Matt Henriksson, CFA
Senior Equity Analyst
Bloomberg Intelligence
Komeil Nasrollahi
Senior Director Innovation & Venture Partnerships
Siemens Healthineers
Dr. Steven Mickelsen
Founder & CTO
Field Medical, Inc.
Mayank Vijayvergia
Head of Strategy, Cardiovascular and Interventional Solutions
GE Healthcare
As neurotech moves from early validation to market scale, success demands aligning capital, clinical evidence, corporate partnerships, and security — the new non-negotiables for health system trust. This panel unpacks what founders must build now to close deals and attract strategic capital in 2026.
Paula Rutledge
Founder & CEO
Legacy MedSearch
Christian Espinosa
CEO
Blue Goat Cyber
Kip Roberts
Vice President – Neurosciences Mergers/Acquisitions & Strategy
Medtronic
Brad Maruca
Managing Director
Deloitte
Edward Ruppel
Founder, General Partner
Ground Effect Ventures
MedTech timelines are often delayed not by technology, but by gaps in regulatory planning, clinical execution, and reimbursement strategy. This panel examines the common pitfalls that derail progress and how founders, advisors, and partners can better anticipate and manage the risks that slow innovation.
Joseph Panetta
Chief Marketing Officer
Ascend CRO
Lynn Carney
Director, Agency and Alliances
Medmarc
Lian Cunningham
VP Clinical Affairs
Endogenex
Mark Swanson
Partner
QRx Partners
Charles Dunham
Shareholder
Greenberg Traurig, LLP
Codi Gharagouzloo, Ph.D.
Scientific Founder & CSO
Imaginostics, Inc.
Carlos Granada
CEO
Zelery Med-Corporation
Mark Khachaturian PhD
CEO
Wellvii
Oren Gelman
President & CEO
Arthrolense
Marc Mackey
CEO
PolarisAR
Irena King, PhD
Founder and CEO
Surgicure Technologies
Longevity is no longer a moonshot — it’s a market. Cellular reprogramming, AI-driven biological age modelling, and senolytic therapeutics are moving from research papers into clinical trials and investment portfolios. This panel brings together the scientists pushing the science, the ecosystem builders scaling the infrastructure, and the founders turning aging biology into deployable products. The question isn’t whether longevity is real — it’s how fast it gets here, and who builds the defining companies.
Maryam Mokhtarzadeh
Chief Medical Officer
Persephoni
Karl Mehta
Partner
Mehta Family Offiice
David Snow
Executive Director
Pegasus Park
Boris Reznik
Chairman & CEO
Immorta Bio
Aubry Tandjeu
Medtech Business Consultant
BiB Consulting
Premium medtech exits aren’t lucky — they’re built. This panel brings together acquirers, investors, and dealmakers to decode what separates the companies that command competitive offers from those that don’t. From early product decisions to due diligence readiness, attendees will leave with a clearer map of what “exit-ready” actually looks like.
Cale Garverick
Managing Director
TD Cowen
Tripp Higgins
Founder | Chairman
Pacemate
Tasneem Dohadwala
Founding Partner
Excelestar Ventures
Rachel Knutton
CEO/Founder
Alluvia Studio
Oren Gelman
President & CEO
Arthrolense
AI in healthcare is no longer a question of if — it’s a question of how. This panel goes behind the technology to examine what it actually takes to build clinical-grade AI, power it at scale, and get health systems to deploy it. From validation and trust to compute infrastructure and enterprise adoption, four leaders from across the stack share what the industry is still getting wrong — and what getting it right looks like.
Hawkins C. Gay, MD, MPH, MSAI
Cardiac Electrophysiologist
Northwestern Medicine, Bluhm Cardiovascular Institute
Sam Seder
Chief Growth Officer
Giga Energy
Joshua M. Lampert, MD, FACC
Cardiac Electrophysiologist & Medical Director of Machine Learning
Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai
Dr. Zahra Timsah
Chief Executive Officer
i-GENTIC AI
Florida is emerging as a powerful force in U.S. MedTech, backed by strong healthcare capital, leading clinical institutions, and real commercial scale. This panel explores why the state is becoming a serious and competitive innovation hub in its own right.
Abby Lindenberg
CEO and Founder
caa
Andrew S. Duffell
President
Research Park at Florida Atlantic University
Mark Glickman
President & CEO
BioFlorida, Inc.
Paul Evans
Associate Vice President of External Affairs
Max Planck Florida Institute for Neuroscience
Dr. Barry T. Katzen, MD
Chief Medical Innovation Officer, Founder & Chief Medical Executive Emeritus
Baptist Health South Florida, Miami Cardiac & Vascular Institute
This fireside will take a capital markets lens to the current MedTech landscape, covering the trends reshaping business models across the sector, the investment outlook for global MedTech equities, and the key considerations driving decisions in today’s market environment. With perspectives from Goldman Sachs, Google, and HSBC, it’s set to be one of the sharper conversations of the conference.
Eileen Ke
Partner
Edge Medical Ventures
David Roman
Managing Director, Co-Head of Healthcare Global Investment Research
Goldman Sachs
Joe Shonkwiler, MD
Healthcare and Life Science Lead, Venture Capital BD
Jonathan Norris
Managing Director
HSBC Innovation Banking
Micheal Haimour
Investor/Board Director
New World Angels
Eric Ulchaker
Managing Partner
Serial Stage Venture Partners (SSVP)
Stephen Borg Balzan
FDI Specialist
Malta Enterprise
Bob Crutchfield
Managing Director, 1824 Health Ventures Fund & South Carolina Health Innovation Fund
Medical University of South Carolina
Shai Policker
Managing Partner
Edge Medical Ventures
Shai Ran Sapir
Cardiovascular Portfolio Manager
Mayo Clinic Ventures
F. Javier Perez, CFA
Director
BlackPoint Capital
Maryam Mokhtarzadeh
Chief Medical Officer
Persephoni
Rachna Dayal
Managing Partner
Sugati Ventures
Branden Rosenhan
Founding Partner
MedMountain Ventures
Nathalya Mamane
Co-Founder and CEO
Anywhere DX
Francesco Petrini
CEO
Sensars US
George Kramer
Founder and CEO
NEOCOR
Jim Fidacaro
CEO/CO-Founder
Sonion Health
Andreas Fercher, PhD
Co-founder and CEO
elyte diagnostics
Shavit Clein
CEO
Thrixen
Jacob Sheffield
CEO & Founder
Bloom Surgical
Meital Segev-Bar
CEO
BioStream
Victor Suturin
Founder CEO
Aliform
Robert Winder
CEO & Co-Founder
Zooly Labs
Invite Only
17:45 – 20:30
Closing Reception is our final networking gathering to wrap up the event, bringing attendees together for relaxed conversations, drinks, and last connections before departure. Open to all ticket types, it’s the perfect moment to reflect on key takeaways, follow up with new contacts, and say “see you next time.”
